Vitamin D and cancer

Journal of Cancer Research and Therapeutics

Volumn 3, Issue 4, 2007, Pages 225-230

  Ali, Minu M ^a,b   Vaidya, V ^a  

^a INSTITUTE OF SCIENCE   (India)

^b LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Cancer; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; COLECALCIFEROL; ERGOCALCIFEROL; HORMONE PRECURSOR; PARICALCITOL; PLACEBO; PROSTATE SPECIFIC ANTIGEN; VITAMIN D; VITAMIN D RECEPTOR;

BREAST CANCER; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CELL CYCLE REGULATION; CLINICAL TRIAL; COLORECTAL CANCER; DEATH CERTIFICATE; DRUG DOSE ESCALATION; DRUG RECEPTOR BINDING; GENE CONTROL; HEALTH SURVEY; HUMAN; INDUSTRIALIZATION; NEOPLASM; NONHUMAN; OVARY CANCER; PROSTATE CANCER; REVIEW; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL;

EID: 39349100851     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.38998     Document Type: Review

References (6)

1. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States. BMC Cancer 2006;10:264-314.
2. Feskanich D, Jing M, Charles SF, Gregory JK, Susan EH, Bruce WH, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8.
3. Schwartz GG, Hall MC, Stindt D, Patton S, Lovato J, Torti FM. Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer. Clin Cancer Res 2005;11:8680-5.
4. Liu G, Wilding G, Staab MJ, Horvath D, Miller K, Dresen A, et al. Phase II study of 1 alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer. Clin Cancer Res 2003;9:4077-83.
5. Wactawski JW, Jane MK, Garnet LA, Annlouise RA, Robert LB, Mary JO, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:2287-8.
6. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate and non-melanoma skin cancer: A composite death certificate based case-control study. Occup Environ Med 2002;59:257-62.